Author:
Makhaeva Galina F.,Lushchekina Sofya V.,Boltneva Natalia P.,Sokolov Vladimir B.,Grigoriev Vladimir V.,Serebryakova Olga G.,Vikhareva Ekaterina A.,Aksinenko Alexey Yu.,Barreto George E.,Aliev Gjumrakch,Bachurin Sergey O.
Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. Salomone, S., Caraci, F., Leggio, G. M., Fedotova, J. & Drago, F. New pharmacological strategies for treatment of Alzheimer’s disease: focus on disease modifying drugs. British journal of clinical pharmacology 73, 504–517, 10.1111/j.1365-2125.2011.04134.x (2012).
2. Youdim, M. B. Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson’s and Alzheimer’s diseases as disease modifying agents. Experimental neurobiology 19, 1–14, 10.5607/en.2010.19.1.1 (2010).
3. Carreiras, M. C., Mendes, E., Perry, M. J., Francisco, A. P. & Marco-Contelles, J. The multifactorial nature of Alzheimer’s disease for developing potential therapeutics. Current topics in medicinal chemistry 13, 1745–1770 (2013).
4. Eisen, A. Amyotrophic lateral sclerosis: A 40-year personal perspective. Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia 16, 505–512, 10.1016/j.jocn.2008.07.072 (2009).
5. Bachurin, S. O. [Medicinal and chemical approaches to focused search of agents for treatment and therapy of Alzheimer disease]. Voprosy meditsinskoi khimii 47, 155–197 (2001).
Cited by
81 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献